TY  - CONF 
AU  - Castrillo Fernández, Azucena
AU  - Arcas Otero, Carina
AU  - Díaz Pereira, Almudena
AU  - Rodríguez Calvo, María Inmaculada
PY  - 2011
SN  - 0041-1132
UR  - http://hdl.handle.net/20.500.11940/6868
AB  - Background/Case Studies: In the past decade, technology for inactivation of potential pathogens and leukocytes in labile blood components has been introduced into Blood Centres to reduce the risk of transfusion-associated adverse effects. Intercept®...
LA  - eng
KW  - Blood Buffy Coat
TI  - In Vitro Evaluation of Platelet Concentrates from Buffy Coat Treated with Two Pathogen Reduction Technology (PRT)
VL  - 51
ER  -